重新审视NYHA I-II级心衰患者的客观评估
该研究基于ReBIC-1试验,比较NYHA I级与II级射血分数降低的稳定性心衰门诊患者的客观功能指标。尽管两组在呼吸困难VAS评分、NT-proBNP和6分钟步行距离上差异有统计学意义,但重叠显著,提示NYHA分级对轻度心衰区分能力差。
要点
- NYHA I级与II级患者客观指标重叠大,分级区分度低
- NYHA I级中19%-34%存在至少一项严重度标志
- 功能分级变化未伴随呼吸困难VAS的相应改变
核心结论
- 大多数NYHA I级和II级患者自我感知的受限、客观体能和利钠肽水平相似,提示NYHA分级对轻度心衰区分能力差。
研究设计与样本
- ReBIC-1试验纳入188例稳定性射血分数降低的心衰门诊患者,基线时按方案同步评估NYHA分级、6分钟步行试验、NT-proBNP和呼吸困难VAS。
主要发现
- NYHA I级患者呼吸困难VAS中位数16(IQR 4-30),II级为27.5(IQR 11-49),p=0.001,但密度重叠60%。
- NT-proBNP中位数I级为620 pg/mL(IQR 248-1333),II级为778 pg/mL(IQR 421-1737),p=0.015,重叠78%。
- 6分钟步行距离I级为400 m(IQR 330-466),II级为351 m(IQR 286-408),p=0.028,重叠64%。
- NYHA I级患者中19%-34%存在一项严重度标志(VAS>30分、6MWT<300 m或NT-proBNP>1000 pg/mL),6%-10%存在两项。
- 功能分级的时序变化未伴随呼吸困难VAS的变化(p=0.14)。
临床怎么用
- 对轻度心衰患者,不应仅依赖NYHA分级评估严重程度,应结合客观指标如6分钟步行试验和NT-proBNP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: New York Heart Association (NYHA) functional class plays a central role in heart failure (HF) assessment but might be unreliable in mild presentations. We compared objective measures of HF functional evaluation between patients classified as NYHA I and II in the Rede Brasileira de Estudos em Insuficiência Cardíaca (ReBIC)-1 Trial. METHODS: The ReBIC-1 Trial included outpatients with stable HF with reduced ejection fraction. All patients had simultaneous protocol-defined assessment of NYHA class, 6 min walk test (6MWT), N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and patient's self-perception of dyspnoea using a Visual Analogue Scale (VAS, range 0-100). RESULTS: Of 188 included patients with HF, 122 (65%) were classified as NYHA I and 66 (35%) as NYHA II at baseline. Although NYHA class I patients had lower dyspnoea VAS Scores (median 16 (IQR, 4-30) for class I vs 27.5 (11-49) for class II, p=0.001), overlap between classes was substantial (density overlap=60%). A similar profile was observed for NT-proBNP levels (620 pg/mL (248-1333) vs 778 (421-1737), p=0.015; overlap=78%) and for 6MWT distance (400 m (330-466) vs 351 m (286-408), p=0.028; overlap=64%). Among NYHA class I patients, 19%-34% had one marker of HF severity (VAS Score >30 points, 6MWT <300 m or NT-proBNP levels >1000 pg/mL) and 6%-10% had two of them. Temporal change in functional class was not accompanied by variation on dyspnoea VAS (p=0.14). CONCLUSIONS: Most patients classified as NYHA classes I and II had similar self-perception of their limitation, objective physical capabilities and levels of natriuretic peptides. These results suggest the NYHA classification poorly discriminates patients with mild HF.
引用
- Blacher M, Zimerman A, Engster PHB, et al. Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II. Heart. 2020. PMID: 33361353. doi:10.1136/heartjnl-2020-317984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。